Novartis Hungária Kft., a subsidiary of the global healthcare leader Novartis AG, is headquartered in Hungary and plays a pivotal role in the pharmaceutical industry. Established in 1996, the company has significantly contributed to the healthcare landscape in Central and Eastern Europe, focusing on innovative medicines and advanced therapies.
Specialising in areas such as oncology, cardiology, and immunology, Novartis Hungária is renowned for its commitment to research and development, delivering unique products that address unmet medical needs. The company’s portfolio includes groundbreaking treatments that leverage cutting-edge technology, positioning it as a leader in the Hungarian market.
With a strong emphasis on patient-centric solutions, Novartis Hungária Kft. continues to achieve notable milestones, reinforcing its reputation as a trusted partner in healthcare innovation.
+71 vs industry average
Novartis Hungária Kft.’s score of 100 is higher than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Novartis Hungária Kft.?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Chemicals is among the most carbon-intensive industries
Industry performance
The Chemicals industry has reduced its overall emissions by 6% since 2019
Reported emissions
No reported emissions data is available for Novartis Hungária Kft. yet.
Novartis Hungária Kft.'s reported carbon emissions
Novartis Hungária Kft. currently does not have specific carbon emissions data available for the most recent year, as indicated by the absence of emissions figures. However, the company is part of a broader corporate family under Novartis AG, which has established significant climate commitments and initiatives.
As a current subsidiary of Novartis AG, Novartis Hungária Kft. inherits its climate targets and initiatives. Novartis AG has committed to various sustainability frameworks, including the Science Based Targets initiative (SBTi), CDP, and RE100, which aim to reduce carbon emissions and transition to renewable energy sources. These commitments reflect a strong corporate responsibility towards mitigating climate change.
While specific reduction targets for Novartis Hungária Kft. are not detailed, the overarching goals set by Novartis AG indicate a commitment to reducing emissions across all scopes, including Scope 1, 2, and 3. The company is actively engaged in initiatives to enhance sustainability and reduce its carbon footprint, aligning with global climate action efforts.
In summary, while Novartis Hungária Kft. does not provide specific emissions data, it is supported by the ambitious climate commitments of its parent company, Novartis AG, which are cascaded down to its subsidiaries.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Novartis Hungária Kft.’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Novartis Hungária Kft. yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives

Science Based Targets Initiative
Inherited from Novartis AG
Carbon Disclosure Project
Inherited from Novartis AGThe Climate Pledge
Inherited from Novartis AGUN Global Compact Climate Champions initiative
RE 100
Inherited from Novartis AGClimate Action 100
Emissions comparison with industry peers
View similar organisationsNo peer comparison is available for Novartis Hungária Kft. yet.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project